JP2024534124A5 - - Google Patents

Info

Publication number
JP2024534124A5
JP2024534124A5 JP2024512008A JP2024512008A JP2024534124A5 JP 2024534124 A5 JP2024534124 A5 JP 2024534124A5 JP 2024512008 A JP2024512008 A JP 2024512008A JP 2024512008 A JP2024512008 A JP 2024512008A JP 2024534124 A5 JP2024534124 A5 JP 2024534124A5
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
acid molecule
molecule according
bacmid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024512008A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534124A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/075280 external-priority patent/WO2023028455A1/en
Publication of JP2024534124A publication Critical patent/JP2024534124A/ja
Publication of JP2024534124A5 publication Critical patent/JP2024534124A5/ja
Pending legal-status Critical Current

Links

JP2024512008A 2021-08-23 2022-08-22 逆位末端反復配列によるクローズドエンドdnaの作製 Pending JP2024534124A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163236215P 2021-08-23 2021-08-23
US63/236,215 2021-08-23
PCT/US2022/075280 WO2023028455A1 (en) 2021-08-23 2022-08-22 Closed-end dna production with inverted terminal repeat sequences

Publications (2)

Publication Number Publication Date
JP2024534124A JP2024534124A (ja) 2024-09-18
JP2024534124A5 true JP2024534124A5 (cg-RX-API-DMAC7.html) 2025-08-29

Family

ID=83849025

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024512008A Pending JP2024534124A (ja) 2021-08-23 2022-08-22 逆位末端反復配列によるクローズドエンドdnaの作製

Country Status (13)

Country Link
US (1) US20230091932A1 (cg-RX-API-DMAC7.html)
EP (1) EP4392445A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024534124A (cg-RX-API-DMAC7.html)
KR (1) KR20240049825A (cg-RX-API-DMAC7.html)
CN (1) CN117881696A (cg-RX-API-DMAC7.html)
AR (1) AR126845A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022334714A1 (cg-RX-API-DMAC7.html)
CA (1) CA3229345A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024001242A2 (cg-RX-API-DMAC7.html)
IL (1) IL310963A (cg-RX-API-DMAC7.html)
MX (1) MX2024002192A (cg-RX-API-DMAC7.html)
TW (1) TW202328174A (cg-RX-API-DMAC7.html)
WO (1) WO2023028455A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020001593A (es) 2017-08-09 2020-07-13 Bioverativ Therapeutics Inc Moleculas de acido nucleico y usos de las mismas.
JP7602454B2 (ja) 2018-08-09 2024-12-18 バイオベラティブ セラピューティクス インコーポレイテッド 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用
JP2025525583A (ja) 2022-07-19 2025-08-05 ランパート バイオサイエンス インコーポレイテッド 非免疫原性環状非ウイルス性dnaベクター
CN120981563A (zh) * 2023-03-24 2025-11-18 南京金斯瑞生物科技有限公司 一种提升质粒稳定性的宿主细胞
WO2024249298A2 (en) * 2023-05-26 2024-12-05 Generation Bio Co. Modified closed-ended dna (cedna) vectors, compositions, and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
EP0279582A3 (en) 1987-02-17 1989-10-18 Pharming B.V. Dna sequences to target proteins to the mammary gland for efficient secretion
US5633076A (en) 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
IE922437A1 (en) 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
CA2149326C (en) 1992-11-13 2007-04-17 Mitchell E. Reff Fully impaired consensus kozak sequences for mammalian expression
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
GB9524973D0 (en) 1995-12-06 1996-02-07 Lynxvale Ltd Viral vectors
RO120148B1 (ro) 1997-03-14 2005-09-30 Idec Pharmaceuticals Corporation Sistem vector şi procedeu de inserţie a unui fragment adn, în genomul celulelor de mamifere
GB0911870D0 (en) * 2009-07-08 2009-08-19 Ucl Business Plc Optimised coding sequence and promoter
AU2014251099B2 (en) * 2013-04-08 2019-01-17 The University Of Kansas Chimeric adeno-associated virus/ bocavirus parvovirus vector
BR112016020688B1 (pt) * 2014-03-09 2024-01-30 The Trustees Of The University Of Pennsylvania Vetores virais recombinantes, vírus adenoassociado recombinante, composição farmacêutica, bem como uso dos mesmos
TWI707951B (zh) 2015-04-08 2020-10-21 美商健臻公司 過大腺相關載體之製造
KR20200057051A (ko) * 2017-09-27 2020-05-25 시질론 테라퓨틱스, 인크. 활성 세포를 포함하는 방법, 조성물 및 이식 가능한 요소
JP7602454B2 (ja) * 2018-08-09 2024-12-18 バイオベラティブ セラピューティクス インコーポレイテッド 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用
KR20210151785A (ko) * 2019-03-13 2021-12-14 제너레이션 바이오 컴퍼니 비바이러스성 dna 벡터 및 fviii 치료제 발현을 위한 이의 용도
EP3736286A1 (en) * 2019-05-09 2020-11-11 Biotest AG Single chain factor viii molecule
MX2023001109A (es) * 2020-07-27 2023-04-24 Anjarium Biosciences Ag Composiciones de moleculas de adn, metodos para elaborar las mismas, y metodos de usos de las mismas.

Similar Documents

Publication Publication Date Title
US20240109938A1 (en) Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
AU2019200949B2 (en) High-transduction-efficiency raav vectors, compositions, and methods of use
US20230129762A1 (en) High-transduction-efficiency raav vectors, compositions, and methods of use
JP7413256B2 (ja) 神経変性疾患の遺伝子治療
US9611302B2 (en) High-transduction-efficiency RAAV vectors, compositions, and methods of use
JP2022517174A5 (cg-RX-API-DMAC7.html)
JP2024150613A (ja) 変異aav、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法
JP2020537544A5 (cg-RX-API-DMAC7.html)
JP2020537542A5 (cg-RX-API-DMAC7.html)
CN104520428A (zh) 将基因转移到细胞、器官和组织的aav载体组合物和方法
US20220193261A1 (en) Compositions useful for treatment of pompe disease
JP7785389B2 (ja) 新規なイントロン断片
JP2024532261A5 (cg-RX-API-DMAC7.html)
EP3613856A1 (en) Shrna expression cassette, polynucleotide sequence carrying same, and application thereof
CN108239645B (zh) 肝脏特异性转录调控序列及其应用
JP2023551254A5 (cg-RX-API-DMAC7.html)
RU2024107452A (ru) Получение днк с замкнутыми концами с последовательностями инвертированных концевых повторов
WO2025065890A1 (zh) 一种重组腺相关病毒颗粒、重组腺相关病毒载体系统及其应用
CN120981475A (zh) 变体aav9衣壳蛋白及其用途
CN118955653A (zh) 腺相关病毒衣壳蛋白的突变体、编码其的核酸及应用
WO2020214526A1 (en) Enhanced transduction of aav vectors encoding micrornas
HK1208683B (en) High-transduction-efficiency raav vectors, compositions, and methods of use